Micro Labs’ efavirenz/lamivudine/tenofovir tablet prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
News
The EOI for human insulin now revised to include long-acting insulin analogues
M
The changes to the EOI for human insulin shown below in bold and italic
First isoniazid/rifapentine generic prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Lupin’s cycloserine capsule prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Macleods’ pyridoxine tablets prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Publication of the Second Edition of the Manual on development and use of FAO and WHO specifications for chemical pesticides
VCP
WHO and FAO are pleased to announce the publication of the second edition of the Manual on development and use of FAO and WHO specifications for chemical pesticides.
Atazanavir/ritonavir tablet prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Trastuzumab 440mg co-packed with bacteriostatic water for injection for multiple dosing prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Paediatric dispersible abacavir/lamivudine tablet prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Micro Labs’ dolutegravir/lamivudine/tenofovir tablet prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Withdrawal of Vector Control TC products and the corresponding reference profiles supporting WHO Specifications
VCP
Recently, seven active ingredient Technical Material (TC) products, previously evaluated by WHO, were withdrawn by the recognized applicants. In so doing, the applicants
ITN Product Review Report
VCP
WHO PQT/VCP recently published the following report - Product Review Report - Insecticide Treated Nets Formulated with Pyrethroid+PBO and Pyrethroid+2nd Ac
Gilead’s remdesivir prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
First nirmatrelvir + ritonavir prequalified for Covid-19
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
New Invitation for Expression of Interest (EOI) for Active Pharmaceutical Ingredients (APIs) published
M
New Invitation for Expression of Interest (EOI) for Active Pharmaceutical Ingredients (APIs) published
Revised Invitation for Expression of Interest (EOI) for medicines against HIV infection and related diseases published
M
The 20th Invitation for Expression of Interest (EOI) for medicines against HIV infection and related diseases, is published with the following changes:
A) The following products
Hetero’s ritonavir prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list: